Montirelin

Montirelin

SCHEMBL3095581

C[C@H]1SC[C@@H](C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N2CCC[C@H]2C(N)=O)NC1=O.O.O.O.O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Montirelin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TRHR P34981 6/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Montirelin SCHEMBL29405744 0.99 TRHR (0.55) TRHR
Montirelin SCHEMBL7311976 0.99 TRHR (0.55) TRHR
Montirelin SCHEMBL3098148 0.99 TRHR (0.55) TRHR
Montirelin SCHEMBL4955895 0.99 TRHR (0.55) TRHR
Montirelin SCHEMBL7354006 0.99 TRHR (0.55) TRHR
Montirelin SCHEMBL8498903 0.95 TRHR (0.52) TRHR
SCHEMBL7318759 0.90 TRHR (0.54) TRHR
SCHEMBL14028667 0.89 TRHR (0.43) TRHR
SCHEMBL7310894 0.88 TRHR (0.52) TRHR
SCHEMBL8257280 0.88 TRHR (0.42) TRHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8568997-B2 Detection system and uses therefor DIMERIX BIOSCIENCE PTY LTD. (AU) 2013-10-29 — — US disclosed
EP-2605015-A1 Kits for determining the interaction of a test compound with two associated receptors Dimerix Bioscience Pty.Ltd. (AU) 2013-06-19 — — EP disclosed
EP-2080012-B1 Methods for assaying test compounds on associated receptors DIMERIX BIOSCIENCE PTY LTD (AU) 2013-03-20 — — EP disclosed
US-20130065253-A1 DETECTION SYSTEM AND USES THEREFOR DIMERIX BIOSCIENCE PTY LTD. (AU) 2013-03-14 — — US disclosed
US-8283127-B2 Detection system and uses therefor DIMERIX BIOSCIENCE PTY LTD. (AU) 2012-10-09 — — US disclosed
US-20100234417-A1 THYROTROPIN RELEASING HORMONE RECEPTOR-OREXIN RECEPTOR HETERO-DIMERS/-OLIGOMERS DIMERIX BIOSCIENCE PTY LTD. (AU) 2010-09-16 — — US disclosed
US-20100021457-A1 DETECTION SYSTEM AND USES THEREFOR DIMERIX BIOSCIENCE PTY LTD. (AU) 2010-01-28 — — US disclosed
EP-2080012-A1 DETECTION SYSTEM AND USES THEREFOR Dimerix Bioscience Pty.Ltd. (AU) 2009-07-22 — — EP disclosed
EP-2078037-A1 THYROTROPIN RELEASING HORMONE RECEPTOR-OREXIN RECEPTOR HETERO-DIMERS/-OLIGOMERS Dimerix Bioscience Pty.Ltd. (AU) 2009-07-15 — — EP disclosed
WO-2008055313-A1 DETECTION SYSTEM AND USES THEREFOR DIMERIX BIOSCIENCE PTY LTD (AU) 2008-05-15 — — WO disclosed
WO-2008055314-A1 THYROTROPIN RELEASING HORMONE RECEPTOR-OREXIN RECEPTOR HETERO-DIMERS/-OLIGOMERS DIMERIX BIOSCIENCE PTY LTD (AU) 2008-05-15 — — WO disclosed
EP-0862429-A4 METHOD OF ADJUSTING THE CIRCADIAN RHYTHM OF A MAMMAL GRUENENTHAL GMBH (DE) 2003-05-28 — — EP disclosed
EP-0866711-A4 METHOD OF INHIBITING SLEEP APNEA GRUENENTHAL GMBH (DE) 2003-04-16 — — EP disclosed
EP-0866711-A1 METHOD OF INHIBITING SLEEP APNEA Grünenthal GmbH (DE) 1998-09-30 — — EP disclosed
EP-0862429-A1 METHOD OF ADJUSTING THE CIRCADIAN RHYTHM OF A MAMMAL Grünenthal GmbH (DE) 1998-09-09 — — EP disclosed
WO-1997015309-A1 METHOD OF INHIBITING SLEEP APNEA GRUENENTHAL, GMBH (DE) 1997-05-01 — — WO disclosed
WO-1997015301-A1 METHOD OF ADJUSTING THE CIRCADIAN RHYTHM OF A MAMMAL GRUENENTHAL GMBH (DE) 1997-05-01 — — WO disclosed
Send feedback